ATE102943T1 - Benzoxazin-verbindungen und ihre pharmazeutische anwendung. - Google Patents

Benzoxazin-verbindungen und ihre pharmazeutische anwendung.

Info

Publication number
ATE102943T1
ATE102943T1 AT88309930T AT88309930T ATE102943T1 AT E102943 T1 ATE102943 T1 AT E102943T1 AT 88309930 T AT88309930 T AT 88309930T AT 88309930 T AT88309930 T AT 88309930T AT E102943 T1 ATE102943 T1 AT E102943T1
Authority
AT
Austria
Prior art keywords
pharmaceutical applications
benzoxazine compounds
compounds
benzoxazine
antiemetics
Prior art date
Application number
AT88309930T
Other languages
English (en)
Inventor
Tetsuya Tahara
Takeshi Kawakita
Mitsuyoshi Yasumoto
Takemi Fukuda
Original Assignee
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP63005415A external-priority patent/JPH01207290A/ja
Application filed by Yoshitomi Pharmaceutical filed Critical Yoshitomi Pharmaceutical
Application granted granted Critical
Publication of ATE102943T1 publication Critical patent/ATE102943T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT88309930T 1987-10-22 1988-10-21 Benzoxazin-verbindungen und ihre pharmazeutische anwendung. ATE102943T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP26795387 1987-10-22
JP33125987 1987-12-25
JP63005415A JPH01207290A (ja) 1987-10-22 1988-01-13 ベンズオキサジン化合物
EP88309930A EP0313393B1 (de) 1987-10-22 1988-10-21 Benzoxazin-Verbindungen und ihre pharmazeutische Anwendung

Publications (1)

Publication Number Publication Date
ATE102943T1 true ATE102943T1 (de) 1994-04-15

Family

ID=27276738

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88309930T ATE102943T1 (de) 1987-10-22 1988-10-21 Benzoxazin-verbindungen und ihre pharmazeutische anwendung.

Country Status (8)

Country Link
US (1) US4892872A (de)
EP (1) EP0313393B1 (de)
JP (1) JPH0228182A (de)
KR (1) KR910000439B1 (de)
AT (1) ATE102943T1 (de)
CA (1) CA1304082C (de)
DE (1) DE3888441T2 (de)
ES (1) ES2061684T3 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122528A (en) * 1983-12-22 1992-06-16 Erbamont, Inc. Analgesic use of benzobicyclic carboxamides
US4933445A (en) * 1988-11-29 1990-06-12 Rorer Pharmaceutical Corporation Heteroazabenzobicyclic carboxamide 5-HT3 antagonists
US5185333A (en) * 1989-07-03 1993-02-09 Yoshitomi Pharmaceutical Industries, Ltd. Benzazine compounds and pharmaceutical uses thereof
DE69026759D1 (de) * 1989-07-03 1996-06-05 Yoshitomi Pharmaceutical Benzazin-Verbindungen und deren pharmazeutische Verwendungen
JP3122671B2 (ja) * 1990-05-23 2001-01-09 協和醗酵工業株式会社 複素環式化合物
GB9120628D0 (en) * 1991-09-27 1991-11-06 Fujisawa Pharmaceutical Co Pyrrolobenzoxazine derivatives and process for preparation thereof
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔3,2−b〕ピリジン誘導体
CN1047076C (zh) * 1993-04-28 1999-12-08 吉富制药株式会社 稳定的注射剂及注射剂的稳定方法
GB9309716D0 (en) * 1993-05-12 1993-06-23 Zeneca Ltd Heterocyclic derivatives
JP3266998B2 (ja) * 1993-09-07 2002-03-18 三菱ウェルファーマ株式会社 1,4−ベンズオキサジン化合物の工業的な製造法
US5723103A (en) * 1994-12-09 1998-03-03 Vanderbilt University Substituted benzamides and radioligand analogs and methods of use
DE60218493D1 (de) * 2001-09-12 2007-04-12 Pharmacia & Upjohn Co Llc Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
JP2006516977A (ja) 2003-01-13 2006-07-13 ダイノゲン ファーマシューティカルズ,インコーポレイテッド 悪心、嘔吐、レッチング、またはそれらの任意の組み合わせの治療方法
KR100879636B1 (ko) * 2007-08-22 2009-01-21 한국과학기술연구원 세로토닌 5―ht₃a 길항적 효과를 갖는 퀴나졸린유도체 함유 약제 조성물
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
DK2432467T3 (en) 2009-05-20 2018-04-16 Inst Nat Sante Rech Med SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS FOR USE IN TREATMENT OF VESTIBULAR DAMAGE LESSONS
CN101786963B (zh) * 2010-03-03 2013-05-08 山东众诚药业股份有限公司 阿扎司琼中间体的合成方法
CN102329313B (zh) * 2011-07-15 2012-09-26 海南灵康制药有限公司 一种盐酸阿扎司琼化合物及其制法
CA2901743C (en) * 2013-02-19 2016-08-30 Roger Linington Benzothiomorpholine and benzomorpholine derivatives as biofilm inhibitors
CN103351386B (zh) * 2013-07-26 2016-05-18 南京正大天晴制药有限公司 一种盐酸阿扎司琼的合成方法
CN103467465B (zh) * 2013-09-02 2016-06-01 扬子江药业集团四川海蓉药业有限公司 一种盐酸阿扎司琼的合成方法
CN104557907B (zh) * 2015-01-21 2016-06-01 扬子江药业集团四川海蓉药业有限公司 一种盐酸阿扎司琼的制备方法
CN104557906A (zh) * 2015-01-21 2015-04-29 扬子江药业集团四川海蓉药业有限公司 一种盐酸阿扎司琼的制备方法
CN107847489B (zh) * 2015-05-18 2021-09-17 森索睿翁公司 用于治疗听力损失的司琼类钙调神经磷酸酶抑制剂
CN105001178B (zh) * 2015-06-29 2019-04-02 上海信谊万象药业股份有限公司 盐酸阿扎司琼中间体的合成方法
CA2996717A1 (en) 2015-09-11 2017-03-16 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
MX384045B (es) 2016-04-14 2025-03-14 Sensorion (+)-azasetrón para su uso en el tratamiento de trastornos del oído.
EA038516B1 (ru) 2016-07-19 2021-09-09 Сенсорьон Композиция для лечения заболеваний уха, содержащая (+)-азасетрон
CN110719778B (zh) 2017-04-24 2024-06-18 才思治疗公司 用于治疗抑郁的组合物和方法
US20220265668A1 (en) 2019-07-25 2022-08-25 Sensorion Treatment and/or prevention of lesions in the central auditory nervous system
CN119136809A (zh) 2022-03-16 2024-12-13 森索睿翁公司 阿扎司琼用于治疗突发性感音神经性听力损失
CN115160341B (zh) * 2022-07-18 2023-07-18 中国医学科学院医学实验动物研究所 苯并噁嗪类化合物及其药物用途
WO2026062170A1 (en) 2024-09-19 2026-03-26 Sensorion Azasetron for the prevention of hearing loss in subjects receiving cisplatin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2509155A1 (de) * 1975-03-03 1976-09-09 Hoechst Ag 1,4-benzoxazinderivate und verfahren zu ihrer herstellung
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
SE460359B (sv) * 1984-01-25 1989-10-02 Glaxo Group Ltd 3-imidazolylmetyltetrahydrokarbazoloner, foerfarande foer framstaellning av dessa och en farmaceutisk komposition
US4717563A (en) * 1986-03-05 1988-01-05 A. H. Robins Company, Inc. 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides in a method for alleviating emesis caused by non-platinum anticancer drugs

Also Published As

Publication number Publication date
DE3888441D1 (de) 1994-04-21
JPH0573752B2 (de) 1993-10-15
JPH0228182A (ja) 1990-01-30
KR890006642A (ko) 1989-06-15
DE3888441T2 (de) 1994-10-20
US4892872A (en) 1990-01-09
EP0313393B1 (de) 1994-03-16
EP0313393A2 (de) 1989-04-26
KR910000439B1 (ko) 1991-01-25
HK1007143A1 (en) 1999-04-01
EP0313393A3 (de) 1991-02-06
CA1304082C (en) 1992-06-23
ES2061684T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
ATE102943T1 (de) Benzoxazin-verbindungen und ihre pharmazeutische anwendung.
DK320587A (da) Nye farmakologiske forbindelser
SE8701348L (sv) Forbettringar av farmaceutiskt godtagabara salter
NO913785D0 (no) Fremgangsmaate for fremstilling av fibrinogenreseptorantagonister.
DE3667665D1 (de) Heterocyclische verbindungen, ihre herstellung und verwendung.
ATE126215T1 (de) Anti-entzündende 4-aminophenol-derivate.
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
FI920197A0 (fi) Antivirala pyrimidinnukleosider.
ATE223373T1 (de) Amidderivate und ihre therapeutische verwendung
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
ATE218142T1 (de) Nitratester von corticoid verbindungen und die therapeutische verwendungen davon
DE3887014D1 (de) Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen.
ATE89556T1 (de) Naphthalenverbindungen und antiallergische und antiinflammatorische pharmazeutische mittel.
SE8404065D0 (sv) Novel biologically active compounds
ATE137223T1 (de) Leukotrien-b4-antagonisten
DE68926972D1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische Anwendungen
DE68919378D1 (de) Thienotriazolodiazepine und ihre pharmazeutische Verwendung.
ATE117724T1 (de) Antibiotikum ge 22270, faktoren a1,a2,a3 und h.
DE69118064D1 (de) Diamino-s-Triazinonderivate und diese enthaltende selbstlöschende polymere Zusammensetzungen
ES2101373T3 (es) Tetrahidrociclopent(b)indol-metaminas y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos.
ES2044100T4 (es) Ciertas combinaciones de antagonistas del &#34;paf&#34; y antihistaminicos y metodos.
ATE144515T1 (de) Pyridylthiazolidinsäureamid-derivate, ihre herstellung und therapeutische verwendungen
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
ATE93855T1 (de) Pyridinium-nitrat, seine herstellung und anwendung.
DE69204733D1 (de) Antibiotikverbindungen und ihre Herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
EEFA Change of the company name